Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Diagnostic utility of bronchoscopy in adults with acute myeloid leukemia and other high-grade myeloid neoplasms.

Buckley SA, Mark NM, Othus M, Estey EH, Patel K, Walter RB.

Leuk Lymphoma. 2019 Mar 11:1-4. doi: 10.1080/10428194.2019.1581933. [Epub ahead of print] No abstract available.

PMID:
30856024
2.

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.

Halpern AB, Othus M, Huebner EM, Scott BL, Hendrie PC, Percival MM, Becker PS, Smith HA, Oehler VG, Orozco JJ, Cassaday RD, Gardner KM, Chen TL, Buckley SA, Orlowski KF, Anwar A, Estey EH, Walter RB.

Haematologica. 2019 Apr;104(4):e143-e146. doi: 10.3324/haematol.2018.204792. Epub 2018 Nov 8. No abstract available.

3.

A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study.

Buckley SA, Percival ME, Othus M, Halpern AB, Huebner EM, Becker PS, Shaw C, Shadman M, Walter RB, Estey EH.

Leuk Lymphoma. 2019 Apr;60(4):1023-1029. doi: 10.1080/10428194.2018.1516036. Epub 2018 Oct 2.

PMID:
30277112
4.

Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms.

Halpern AB, Othus M, Huebner EM, Scott BL, Becker PS, Percival MM, Hendrie PC, Gardner KM, Chen TL, Buckley SA, Orlowski KF, Anwar A, Appelbaum FR, Erba HP, Estey EH, Walter RB.

Leukemia. 2018 Nov;32(11):2352-2362. doi: 10.1038/s41375-018-0135-8. Epub 2018 Apr 17.

5.

Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin.

Moon AM, Buckley SA, Mark NM.

ACG Case Rep J. 2018 Jan 3;5:e3. doi: 10.14309/crj.2018.3. eCollection 2018.

6.

Patient-reported outcomes in acute myeloid leukemia: Where are we now?

Buckley SA, Kirtane K, Walter RB, Lee SJ, Lyman GH.

Blood Rev. 2018 Jan;32(1):81-87. doi: 10.1016/j.blre.2017.08.010. Epub 2017 Sep 1. Review.

PMID:
28888621
7.

Quality of life from the perspective of the patient with acute myeloid leukemia.

Buckley SA, Jimenez-Sahagun D, Othus M, Walter RB, Lee SJ.

Cancer. 2018 Jan 1;124(1):145-152. doi: 10.1002/cncr.30982. Epub 2017 Sep 7.

8.

Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study.

Halpern AB, Othus M, Huebner EM, Buckley SA, Pogosova-Agadjanyan EL, Orlowski KF, Scott BL, Becker PS, Hendrie PC, Chen TL, Percival MM, Estey EH, Stirewalt DL, Walter RB.

Leukemia. 2017 Dec;31(12):2560-2567. doi: 10.1038/leu.2017.165. Epub 2017 May 30.

9.

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis.

Buckley SA, Wood BL, Othus M, Hourigan CS, Ustun C, Linden MA, DeFor TE, Malagola M, Anthias C, Valkova V, Kanakry CG, Gruhn B, Buccisano F, Devine B, Walter RB.

Haematologica. 2017 May;102(5):865-873. doi: 10.3324/haematol.2016.159343. Epub 2017 Jan 25. Review.

10.

Queen Nefertari, the Royal Spouse of Pharaoh Ramses II: A Multidisciplinary Investigation of the Mummified Remains Found in Her Tomb (QV66).

Habicht ME, Bianucci R, Buckley SA, Fletcher J, Bouwman AS, Öhrström LM, Seiler R, Galassi FM, Hajdas I, Vassilika E, Böni T, Henneberg M, Rühli FJ.

PLoS One. 2016 Nov 30;11(11):e0166571. doi: 10.1371/journal.pone.0166571. eCollection 2016.

11.

Lymphomatoid granulomatosis associated with azathioprine use for immune-mediated neuropathy.

Burwick N, Buckley SA, Dong ZM, Richard RE.

BMJ Case Rep. 2016 Sep 26;2016. pii: bcr2016216930. doi: 10.1136/bcr-2016-216930.

12.

Measuring quality of life in acute myeloid leukemia: limitations and future directions.

Buckley SA, Lee SJ, Walter RB.

Expert Rev Hematol. 2016 Sep;9(9):821-3. doi: 10.1080/17474086.2016.1211006. Epub 2016 Aug 2. No abstract available.

13.

Outpatient care of patients with acute myeloid leukemia: Benefits, barriers, and future considerations.

Vaughn JE, Buckley SA, Walter RB.

Leuk Res. 2016 Jun;45:53-8. doi: 10.1016/j.leukres.2016.03.011. Epub 2016 Apr 1. Review.

14.

Prediction of early death in adults with relapsed or refractory acute myeloid leukemia.

Godwin CD, Othus M, Powell MA, Buckley SA, Estey EH, Walter RB.

Leuk Lymphoma. 2016 Oct;57(10):2421-4. doi: 10.3109/10428194.2015.1135436. Epub 2016 Jan 11. No abstract available.

15.

Antigen-specific immunotherapies for acute myeloid leukemia.

Buckley SA, Walter RB.

Hematology Am Soc Hematol Educ Program. 2015;2015:584-95. doi: 10.1182/asheducation-2015.1.584. Review.

PMID:
26637776
16.

Update on antigen-specific immunotherapy of acute myeloid leukemia.

Buckley SA, Walter RB.

Curr Hematol Malig Rep. 2015 Jun;10(2):65-75. doi: 10.1007/s11899-015-0250-9. Review.

PMID:
25896530
17.

Diagnostic Utility of Food Terminology: Culinary Clues for the Astute Diagnostician.

Mark NM, Lessing JN, Buckley SA, Tierney LM Jr.

Am J Med. 2015 Sep;128(9):933-5. doi: 10.1016/j.amjmed.2015.03.018. Epub 2015 Apr 8. No abstract available.

PMID:
25863151
18.

A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age.

Buckley SA, Mawad R, Gooley TA, Becker PS, Sandhu V, Hendrie P, Scott BL, Wood BL, Walter RB, Smith K, Dean C, Estey EH, Pagel JM.

Br J Haematol. 2015 Aug;170(3):349-55. doi: 10.1111/bjh.13437. Epub 2015 Apr 8.

PMID:
25854284
19.

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy.

Buckley SA, Othus M, Estey EH, Walter RB.

Blood Cancer J. 2015 Jan 30;5:e276. doi: 10.1038/bcj.2014.97. No abstract available.

20.

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.

Walter RB, Sandmaier BM, Storer BE, Godwin CD, Buckley SA, Pagel JM, Sorror ML, Deeg HJ, Storb R, Appelbaum FR.

Biol Blood Marrow Transplant. 2015 Feb;21(2):373-8. doi: 10.1016/j.bbmt.2014.09.022. Epub 2014 Sep 30.

21.

Evidence for prehistoric origins of Egyptian mummification in late Neolithic burials.

Jones J, Higham TF, Oldfield R, O'Connor TP, Buckley SA.

PLoS One. 2014 Aug 13;9(8):e103608. doi: 10.1371/journal.pone.0103608. eCollection 2014.

22.

Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation.

Walter RB, Gyurkocza B, Storer BE, Godwin CD, Pagel JM, Buckley SA, Sorror ML, Wood BL, Storb R, Appelbaum FR, Sandmaier BM.

Leukemia. 2015 Jan;29(1):137-44. doi: 10.1038/leu.2014.173. Epub 2014 Jun 3.

23.

Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.

Buckley SA, Othus M, Vainstein V, Abkowitz JL, Estey EH, Walter RB.

Am J Hematol. 2014 Apr;89(4):423-8. doi: 10.1002/ajh.23661. Epub 2014 Feb 24.

24.

Rapid rate of peripheral blood blast clearance accurately predicts complete remission in acute myeloid leukemia.

Vainstein V, Buckley SA, Shukron O, Estey EH, Abkowitz JL, Wood BL, Walter RB.

Leukemia. 2014 Mar;28(3):713-6. doi: 10.1038/leu.2013.341. Epub 2013 Nov 18. No abstract available.

PMID:
24240201
25.

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.

Walter RB, Buckley SA, Pagel JM, Wood BL, Storer BE, Sandmaier BM, Fang M, Gyurkocza B, Delaney C, Radich JP, Estey EH, Appelbaum FR.

Blood. 2013 Sep 5;122(10):1813-21. doi: 10.1182/blood-2013-06-506725. Epub 2013 Jul 11.

26.

Height as an explanatory factor for sex differences in human cancer.

Walter RB, Brasky TM, Buckley SA, Potter JD, White E.

J Natl Cancer Inst. 2013 Jun 19;105(12):860-8. doi: 10.1093/jnci/djt102. Epub 2013 May 24.

27.

Livedo reticularis in a patient with pheochromocytoma resolving after adrenalectomy.

Buckley SA, Lessing JN, Mark NM.

J Clin Endocrinol Metab. 2013 Feb;98(2):439-40. doi: 10.1210/jc.2012-2842. Epub 2012 Dec 28. No abstract available.

PMID:
23275529
28.

Regular recreational physical activity and risk of hematologic malignancies: results from the prospective VITamins And lifestyle (VITAL) study.

Walter RB, Buckley SA, White E.

Ann Oncol. 2013 May;24(5):1370-7. doi: 10.1093/annonc/mds631. Epub 2012 Dec 17.

29.

Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia.

Buckley SA, Appelbaum FR, Walter RB.

Bone Marrow Transplant. 2013 May;48(5):630-41. doi: 10.1038/bmt.2012.139. Epub 2012 Jul 23. Review.

PMID:
22825427
30.

Complex organic chemical balms of Pharaonic animal mummies.

Buckley SA, Clark KA, Evershed RP.

Nature. 2004 Sep 16;431(7006):294-9.

PMID:
15372029
31.

Chemistry of archaeological animal fats.

Evershed RP, Dudd SN, Copley MS, Berstan R, Stott AW, Mottram H, Buckley SA, Crossman Z.

Acc Chem Res. 2002 Aug;35(8):660-8. Review.

PMID:
12186571
32.

Effect of oral sodium chlorate administration on Escherichia coli O157:H7 in the gut of experimentally infected pigs.

Anderson RC, Callaway TR, Buckley SA, Anderson TJ, Genovese KJ, Sheffield CL, Nisbet DJ.

Int J Food Microbiol. 2001 Dec 30;71(2-3):125-30.

PMID:
11789929
33.

Organic chemistry of embalming agents in Pharaonic and Graeco-Roman mummies.

Buckley SA, Evershed RP.

Nature. 2001 Oct 25;413(6858):837-41.

PMID:
11677605
34.

Prevalence of antimicrobial resistance in Salmonellae isolated from market-age swine.

Farrington LA, Harvey RB, Buckley SA, Droleskey RE, Nisbet DJ, Inskip PD.

J Food Prot. 2001 Oct;64(10):1496-502.

PMID:
11601696
35.
36.

Effect of sodium chlorate on Salmonella typhimurium concentrations in the weaned pig gut.

Anderson RC, Buckley SA, Callaway TR, Genovese KJ, Kubena LF, Harvey RB, Nisbet DJ.

J Food Prot. 2001 Feb;64(2):255-8.

PMID:
11271777
37.

Inhibition of in vitro Salmonella Typhimurium colonization in porcine cecal bacteria continuous-flow competitive exclusion culturest.

Hume ME, Nisbet DJ, Buckley SA, Ziprin RL, Anderson RC, Stanker LH.

J Food Prot. 2001 Jan;64(1):17-22.

PMID:
11198435
38.

Bactericidal effect of sodium chlorate on Escherichia coli O157:H7 and Salmonella typhimurium DT104 in rumen contents in vitro.

Anderson RC, Buckley SA, Kubena LF, Stanker LH, Harvey RB, Nisbet DJ.

J Food Prot. 2000 Aug;63(8):1038-42.

PMID:
10945577
39.
40.

A preliminary survey of antibiotic resistance of Salmonella in market-age swine.

Farrington LA, Harvey RB, Buckley SA, Stanker LH, Inskip PD.

Adv Exp Med Biol. 1999;473:291-7.

PMID:
10659370
42.

Immunosorbents coupled on-line with liquid chromatography for the determination of fluoroquinolones in chicken liver.

Holtzapple CK, Buckley SA, Stanker LH.

J Agric Food Chem. 1999 Jul;47(7):2963-8.

PMID:
10552594
44.
45.

Anterior segment complications of indirect diode laser in diabetic patients.

Buckley SA, Parmar DN, Jackson H, McHugh JD, Hunter PA.

Br J Ophthalmol. 1998 Dec;82(12):1447-8. No abstract available.

46.

Efficacy of various inorganic sorbents to reduce the toxicity of aflatoxin and T-2 toxin in broiler chickens.

Bailey RH, Kubena LF, Harvey RB, Buckley SA, Rottinghaus GE.

Poult Sci. 1998 Nov;77(11):1623-30.

PMID:
9835335
47.

Effects of a hydrated sodium calcium aluminosilicate (T-Bind) on mycotoxicosis in young broiler chickens.

Kubena LF, Harvey RB, Bailey RH, Buckley SA, Rottinghaus GE.

Poult Sci. 1998 Oct;77(10):1502-9.

PMID:
9776058
48.

Aflatoxicosis in turkey poults is prevented by treatment of naturally contaminated corn with ozone generated by electrolysis.

McKenzie KS, Kubena LF, Denvir AJ, Rogers TD, Hitchens GD, Bailey RH, Harvey RB, Buckley SA, Phillips TD.

Poult Sci. 1998 Aug;77(8):1094-102.

PMID:
9706072
49.

Experimental and natural infection of early weaned pigs with Salmonella choleraesuis.

Anderson RC, Nisbet DJ, Buckley SA, Genovese KJ, Harvey RB, Deloach JR, Keith NK, Stanker LH.

Res Vet Sci. 1998 May-Jun;64(3):261-2.

PMID:
9690614
50.

Supplemental Content

Loading ...
Support Center